Corton Capital’s CorMedix CRMD Stock Holding History

Corton Capital’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$229K	Buy	19,667 +8,626	+78%	+$104K	0.56%	75
2025 Q2	$136K	Buy	+11,041	New	+$122K	0.16%	291

Other funds holding CRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Corton Capital's CRMD Position: Q3 2025 in Review

Corton Capital increased its CorMedix (CRMD) stake by 78% in Q3 2025, buying an estimated $104K and bringing the position to 19,667 shares worth $229K. The position accounts for 0.56% of the portfolio, ranked #75.

Corton Capital first reported a position in CRMD in Q2 2025 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

Corton Capital held 19,667 shares of CorMedix worth $229K as of Q3 2025.
Corton Capital bought 8,626 CorMedix shares in Q3 2025, an estimated $104K.
CorMedix made up 0.56% of Corton Capital's portfolio in Q3 2025, its #75 holding.
Corton Capital first reported a position in CorMedix in Q2 2025 and has held it in 2 quarters since.
190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.